On June 10, 2026 BostonGene, leading developer of AI models for tumor and immune biology, reported its participation at the 22nd Annual Industry/Academia Precision Oncology & RadMed Symposium. At this premier event, global leaders in life sciences will explore the latest innovations in AI, immuno-oncology, molecular imaging, and targeted therapies. The symposium will be held on Thursday, June 11, 2026, at The Alexandria at Torrey Pines Conference Center in San Diego, California.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation details:
Title: Beyond Multiomics: Leveraging AI Foundation Models to Decode the Tumor-Immune Interface
Date & time: Thursday, June 11 | 1:25 PM PST
Speaker: Michael F. Goldberg, PhD, VP of R&D, BostonGene
The presentation will showcase how BostonGene utilizes advanced AI architecture and foundation models to integrate multimodal oncology and immunology data spanning molecular, tissue, cellular, and patient levels to deliver deep biological insights and accelerate drug development. Trained on extensive data points across multiple indications, this model generates high-dimensional embeddings that significantly improve the prediction of immunotherapy response and toxicity profiles.
Dr. Goldberg will highlight how AI-based analysis of minimally invasive peripheral blood immune profiling can support clinical development. The presentation will include key findings from a large-scale clinical collaborative study, demonstrating how the platform predicts patient response and toxicity, mitigates overfitting, and unlocks rare biological signals to guide patient stratification.
To learn more or to schedule a meeting with BostonGene during the event, please contact Hannah Oman at [email protected]. For additional details, visit the 22nd Annual Industry/Academia Precision Oncology & RadMed Symposium website.
(Press release, BostonGene, JUN 10, 2026, View Source [SID1234666554])